NCT04319757 2024-12-05ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid TumorsAcepodia Biotech, Inc.Phase 1 Completed12 enrolled
NCT06505551 2024-07-17Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive CarcinomaSCG Cell Therapy Pte. Ltd.Phase 1/2 Not yet recruiting66 enrolled
NCT05952947 2024-02-02HRYZ-T101 Injection for HPV18 Positive Solid TumorHRYZ Biotech Co.Phase 1 Recruiting32 enrolled
NCT05069935 2023-09-21FT538 in Combination With Monoclonal Antibodies in Advanced Solid TumorsFate TherapeuticsPhase 1 Terminated16 enrolled
NCT05395052 2023-09-21FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid TumorsFate TherapeuticsPhase 1 Terminated5 enrolled
NCT03841110 2023-05-01FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid TumorsFate TherapeuticsPhase 1 Completed37 enrolled
NCT04596033 2022-07-15TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell TherapyGenocea Biosciences, Inc.Phase 1 Terminated49 enrolled
NCT05122221 2022-06-28CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck CancersCorregene Biotechnology Co., LtdPhase 1 Unknown12 enrolled